# PepGen Inc. (PEPG)

> Source: Nexqual · https://nexqual.com/PEPG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, PepGen Inc. (PEPG), nexqual.com/PEPG" · informational, not investment advice.

**Price:** USD 2.7 (-0.74% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 2.72 · day 2.65–2.83 · 52w 1.31–7.8 · market cap $187M · NMS

## Key facts
- 1 of 80 tracked superinvestors hold PEPG (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Total return with dividends: 1Y -40.0% vs S&P 500 +14.9%; 5Y -79.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-11, EPS estimate USD -0.27, revenue estimate $0K.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold PEPG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Viking Global | Viking Global Investors | 0.02% | $6.3M | Unchanged |

## Analysts
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | HC Wainwright & Co. | Reiterated | Buy | $20 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2022-05-02) |
|---|---|---|
| Total return | -40.0% | -79.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -40.1% | -29.5% |
| Volatility (annualized) | 126.5% | 133.1% |
| Max drawdown | -81.2% (Jan 2026→Jun 2026) | -94.2% (Jul 2024→Aug 2025) |

## Peers (Biotechnology)
LGND (Ligand Pharmaceuticals Incorpor) USD 307.82 -2.21% · RYTM (Rhythm Pharmaceuticals, Inc.) USD 90.9 +2.57% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.14 -3.28% · PRAX (Praxis Precision Medicines, Inc) USD 258.92 +0.96% · IONS (Ionis Pharmaceuticals, Inc.) USD 43.91 -0.81% · ABVX (Abivax SA) USD 90.23 -3.49%

## More
Full page: https://nexqual.com/PEPG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $-0.27 | $-0.28 | -0.6% | $0 | 6 |
| Next quarter (ends 2026-12-31) | $-0.31 | $-0.28 | +10.7% | $0 | 6 |
| Current fiscal year (ends 2026-12-31) | $-1.10 | $-1.08 | +2.2% | $0 | 6 |
| Next fiscal year (ends 2027-12-31) | $-1.06 | $-1.08 | -1.7% | $0 | 6 |